Retraction Notice to: TNFAIP8 Promotes Cisplatin Chemoresistance in Triple-Negative Breast Cancer by Repressing p53-Mediated miR-205-5p Expression

Detalles Bibliográficos
Autores principales: Ma, Hong-Yu, Li, Yang, Yin, Hui-Zi, Yin, Hang, Qu, Yuan-Yuan, Xu, Qing-Yong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society of Gene & Cell Therapy 2023
Materias:
Retraction
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10565844/
https://www.ncbi.nlm.nih.gov/pubmed/37829327
http://dx.doi.org/10.1016/j.omtn.2023.102048

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10565844/
https://www.ncbi.nlm.nih.gov/pubmed/37829327
http://dx.doi.org/10.1016/j.omtn.2023.102048

Ejemplares similares